ChemMedChem · 2011 · 42 citations · 17 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryProdrug DesignStructure-activity RelationshipsEnzyme InhibitionStructure-activity Relationship Analysis
Virtual screening efforts have identified several novel HDAC6 inhibitors with cellular isoform selectivity. In particular, a carbamate-protected hydroxamic acid exhibited improved effects with respect to protein hyperacetylation compared with the parent hydroxamate, possibly because of improved cell permeability. The carbamate structure therefore represents a potential prodrug concept for hydroxamic acid-containing HDAC inhibitors.
17
HDAC6 is a microtubule-associated deacetylase
Charlotte Hubbert, Amaris R. Guardiola, Rong Shao et al. · Nature · 2002 · 2.4K citations
The Human Sir2 Ortholog, SIRT2, Is an NAD+-Dependent Tubulin Deacetylase
Brian J. North, Brett Marshall, Margie T. Borra et al. · Molecular Cell · 2003 · 1.5K citations · Full text
Stephen J. Haggarty, Kathryn M. Koeller, Jason Chun Yu Wong et al. · Proceedings of the National Academy of Sciences · 2003 · 1.1K citations · Full text
Teru Hideshima, James E. Bradner, Jason Chun Yu Wong et al. · Proceedings of the National Academy of Sciences · 2005 · 596 citations · Full text
Medicine, Oncology, Pharmacology +14